2023年4月28日 · Learn about innovative treatments for the most common type of liver cancer (hepatocellular carcinoma, or HCC), including liver transplant and ablation.

Hepatocellular carcinoma (HCC) is cancer in your liver. Although it can be life-threatening, catching it early can mean successful treatment with surgery or a liver transplant. Other treatments ease your symptoms and help you live longer.

People with resectable cancer that recurs in the liver might be eligible for further surgery or local treatments like ablation or embolization. If the cancer is widespread, targeted therapy, immunotherapy, or chemotherapy drugs may be options.

2023年4月28日 · Learn how doctors use surgery, liver transplant, radiation, chemotherapy and other methods to treat hepatocellular carcinoma and other types of liver cancer.

2022年10月31日 · Clinical features and diagnosis of hepatocellular carcinoma; Epidemiology and risk factors for hepatocellular carcinoma; Hepatitis B virus reactivation associated with immunosuppressive therapy; Liver transplantation for hepatocellular carcinoma

2022年11月10日 · Hepatocellular carcinoma is a cancer that starts in your liver. It's different from "secondary" liver cancers, which have spread to the liver from other organs. If caught early, it can...

2024年5月9日 · Liver cancer includes two major types: hepatocellular carcinoma (HCC) and intrahepatic bile duct cancer. For information about bile duct cancer, see Bile Duct Cancer (Cholangiocarcinoma) Treatment. For more information about other, less common types of liver cancer, see the Cellular Classification of Primary Liver Cancer section.

There are many factors your doctor will consider when planning your treatment, including the size of the tumors and the severity of the liver disease. Treatment options include surgical removal and liver transplantation. Learn more about liver cancer treatment. Hepatocellular carcinoma (HCC), or liver cancer, occurs when a tumor grows on the liver.

2023年4月14日 · How did the IMBrave150 clinical trial change hepatocellular carcinoma treatment? The IMBrave150 Phase III clinical trial combined an immune checkpoint inhibitor called atezolizumab with bevacizumab, a targeted anti-EGFR therapy that starves tumors by preventing new blood vessels from growing.

2023年11月30日 · In the early stages of hepatocellular carcinoma (HCC), doctors may recommend surgical removal, a liver transplant, or ablation. Learn more about treating HCC here.